Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)
| 25.81 Delayed Data As of 3:59pm ET |  -0.86 / -3.22%Today’s Change | 16.50 Today|||52-Week Range 32.67 | +17.16% Year-to-Date |
Latest DRNA News | Press Releases
| Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript 4:00pm / MotleyFool.com - Paid Partner Content | Dicerna Pharmaceuticals Inc (DRNA) Chief Scientific Ofr. ... May 04 / GuruFocus News - Paid Partner Content |
| Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Lags Revenue Estimates May 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 26.67 |
| Today’s open | 27.11 |
| Day’s range | 25.63 - 27.47 |
| Volume | 41,608 |
| Average volume (3 months) | 785,221 |
| Market cap | $2.4B |
Data as of 3:59pm ET, 05/07/2021
Growth & Valuation
| Earnings growth (last year) | +13.67% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +587.36% |
| P/E ratio | NM |
| Price/Sales | 9.95 |
| Price/Book | 17.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXSMAxsome Therapeutics ... | +0.53 | +0.94% |
| RCUSArcus Biosciences In... | +0.31 | +1.03% |
| ---- | ||
| OCGNOcugen Inc | -0.39 | -4.07% |
Data as of 7:55pm ET, 05/07/2021
Financials
| Last reporting date | May 7, 2021 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $164.3M |
| Annual profit (last year) | -$112.7M |
| Net profit margin | -68.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
